Welcome. If you're a registered user, please log-in. If not, please sign-up.
  • registrations@informa-ls.com
  • phone:+44(0)20 7017 7481
  • GO

Stability Testing 2010

Bringing together leading industry experts to discuss regulations and best-practice methods

Informa Life Sciences’ annual Stability Testing conference will focus on clarifying stability testing regulations and requirements to maximise access to global markets, reduce outlays and minimise costly product recalls. 

The conference will feature important discussions regarding the new WHO stability guideline on global testing, including what the changes mean for stability testing, dossier preparation and product approval.

Delegates will have the opportunity to learn from 15 industry experts.  Use this opportunity to hear numerous case studies of industry successes and failures with stability testing techniques and dossier preparation, to ensure that your stability programmes are on the right track!

Expert Panel

Expert Panel

Manuel Zahn Managing Director 3R Pharma Consulting

Geoff Carr Director Analytical Development Patheon Inc.

David Elder Product Development Director GlaxoSmithKline

Manfred Fischer Head of Analytical Department and Quality Control SkyePharma

Nynke Brouwer Pharmaceutical Assessor RIVM

  • George Johnson, Director Analytical Stability and Technology, Pfizer
  • Kasra Afsarinejad, Principal Scientist, Statistical Science Director, AstraZeneca, Sweden
  • Tila Balasuriya, Group Leader Stability, Bristol Myers Squibb Pharmaceuticals, UK

see more


..

Event Exhibitors

..
..
..
..

Media Partners

..
..
..

23 March 2010: Evening Seminar

Outsourcing: Maintaining Economies During a Recessionary Climate

25 March 2010: Post-conference workshop

Evaluation of Analytical Data from Stability Studies including Dealing with OOS Results

Led by: Geoff Carr, Director of Analytical Development, Patheon Inc.

Companies attending last year included:

Lek Pharmaceuticals Schering Plough Novo Nordisk Medochemie Merck Serono Bristol Myers Squibb
Janssen Cilag Baxter Stiefel Bayer Healthcare Boston Scientific GlaxoSmithKline
Chiesi Farmaceutici Hemofarm Proctor & Gamble Pharmaceuticals TEVA Pharmaceutical TRION Pharma Solvay Pharmaceuticals
Sanofi Pasteur Novartis Takeda Pharmaceuticals

Dates and Venues

23 Mar 2010 - 24 Mar 2010

Hilton London Olympia

Poll

Which statement best describes your company’s situation:

 
 


 

Reviews

"Very interesting two days, with many topics covered relating to stability management, data handling and reporting, packaging and regulatory issues"
QC Supervisor
Stiefel
"Excellent overview on the hot topics of formal stability studies"
Section Leader
F.Hoffmann La Roche

Bookmark and Share